Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Charles F. Wagner Jr.

At a glance: Charles F. Wagner Jr. is Evp, Co & Fo at Vertex Pharmaceuticals (VRTX). Their latest SEC Form 4, filed Nov 16, 2026, reported a sale of $8.4M. On file: 0 purchase lines ($0) and 4 sale lines ($19.2M).

Disclosed holdings: about $16.6M of VRTX stock: 31,764 shares reported on their latest Form 4 (filed Nov 16, 2026), valued at the Nov 19, 2026 close of $521.30. This counts only VRTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Evp, Co & Fo at Vertex Pharmaceuticals Inc / Ma (VRTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $19.2M

Charles F. Wagner Jr.'s InsiderPrint

4 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Charles F. Wagner Jr.: 4 trades, 2025 to 20262025: 0 buys, 2 sales2026: 0 buys, 2 sales

Reading this print: Almost only sells, trading about 4 times a year, typically $4.4M a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (4)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Anthony KoblinskiCEO · KRMN · 100% match
  2. John T. ChambersDirector · BE · 100% match
  3. Walter J. SchellerCEO · HCC · 100% match
  4. Jesse K. BrayCEO · RKT · 100% match
  5. Jonathan LumCOO · CACC · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 16SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 15,28631,764 held (−32%) $547.87 $8.4M -4.8%
Jan 8SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 9,53237,725 held (−20%) $461.00 $4.4M +13.1%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 7,00044,725 held (−14%) $451.00 $3.2M +15.6%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 7,00037,725 held (−16%) $461.00 $3.2M +13.1%
  • Sell

    Evp, Co & Fo Charles F Wagner Jr. sold $8.4M of VRTX at $547.87 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Co & Fo Charles F Wagner Jr. sold $4.4M of VRTX at $461.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Co & Fo Charles F Wagner Jr. sold $3.2M of VRTX at $451.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp, Co & Fo Charles F Wagner Jr. sold $3.2M of VRTX at $461.00 — pre-scheduled 10b5-1 plan sale.

Follow Charles F. Wagner Jr.

Get one email when Charles F. Wagner Jr. files a new purchase or sale. Free.

At most one email a day about Charles F. Wagner Jr., plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.